Pancreas Transplant as Treatment to Arrest Renal Function Decline in Patients With Type 1 Diabetes and Proteinuria

Seminars in Nephrology

Volumn 32, Issue 5, 2012, Pages 432-436

  Cantarovich, Diego ^a   Perrone, Vittorio ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Pancreas transplant; proteinuria; renal function; type 1 diabetes

Indexed keywords

ALBUMIN; CORTICOSTEROID; CREATININE; GLUCOSE; IMMUNOMODULATING AGENT; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ALBUMINURIA; ARTICLE; COHORT ANALYSIS; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KETOACIDOSIS; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY PANCREAS TRANSPLANTATION; METHODOLOGY; NEPHROTOXICITY; OBSERVATIONAL STUDY; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; PROTEINURIA; RISK REDUCTION;

DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; HUMANS; KIDNEY FAILURE, CHRONIC; PANCREAS TRANSPLANTATION; PROTEINURIA; TIME FACTORS;

EID: 84867386157     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2012.07.005     Document Type: Article

References (29)

1. Krolewski A.S., Bonventre J.V. High risk of ESRD in type 1 diabetes: new strategies are needed to retard progressive renal function decline. Semin Nephrol 2012, 32:407-414.
2. Rosolowsky E.T., Skupien J., Smiles A.M., Niewczas M., Roshan B., Stanton R., et al. Risk for ESRD in type 1 diabetes remains high despite renoprotection. J Am Soc Nephrol 2011, 22:545-553.
3. Forsblom C., Harjutsalo V., Thorn L.M., Wadén J., Tolonen N., Saraheimo M., et al. Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol 2011, 22:537-544.
4. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med 2011, 365:2366-2376. The DCCT/EDIC Research Group.
5. Goel G., Perkins B.A. Can improved glycemic control slow renal function decline at all stages of diabetic nephropathy?. Semin Nephrol 2012, 32:423-431.
6. White S.A. Pancreas transplantation. Lancet 2009, 373:1808-1817.
7. Shapiro A.M., Lakey J.R., Ryan E.A., Korbutt G.S., Toth E., Warnock G.L., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000, 343:230-238.
8. Pileggi A., Ricordi C., Kenyon N.S., Froud T., Baidal D.A., Kahn A., et al. Twenty years of clinical islet transplantation at the diabetes research institute-University of Miami. Clin Transpl 2004, 177-204.
9. Perosa M., Boggi U., Cantarovich D., Robertson P. Pancreas transplantation outside the USA: an update. Curr Opin Organ Transplant 2011 Jan 3, Epub ahead of print.
10. Pancreas and islet transplantation. Diabetes Care 2006, 29:935. American Diabetes Association.
11. Gruessner R.W., Sutherland D.E., Kandaswamy R., Gruessner A.C. Over 500 solitary pancreas transplants in non-uremic patients with brittle diabetes mellitus. Transplantation 2008, 85:42-47.
12. Sutherland D.E., Gruessner A.C. Long term results after pancreas transplantation. Transplant Proc 2007, 39:2323-2325.
13. Larsen J.L. Pancreas transplantation: indications and consequences. Endocr Rev 2004, 25:919-946.
14. Fioretto P., Steffes M.W., Sutherland D.E., Goetz F.C., Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998, 339:69-75.
15. Gremizzi C., Vergani A., Paloschi V., Secchi A. Impact of pancreas transplantation on type 1 diabetes-related complications. Curr Opin Organ Transplant 2010, 15:119-123.
16. Giannarelli R., Coppelli A., Sartini M.S., Del Chiaro M., Vistoli F., Rizzo G., et al. Pancreas transplant alone has beneficial effects on retinopathy in type 1 diabetic patients. Diabetologia 2006, 49:2977-2982.
17. Coppelli A., Giannarelli R., Vistoli F., Del Prato S., Rizzo G., Mosca F., et al. The beneficial effects of pancreas transplant alone on diabetic nephropathy. Diabetes Care 2005, 28:1366-1370.
18. Coppelli A., Giannarelli R., Mariotti R., Rondinini L., Fossati N., Vistoli F., et al. Pancreas transplant alone determines early improvement of cardiovascular risk factors and cardiac function in type 1 diabetic patients. Transplantation 2003, 76:974-976.
19. Coppelli A., Giannarelli R., Boggi U., Del Prato S., Amorese G., Vistoli F., et al. Disappearance of nephrotic syndrome in type 1 diabetic patients following pancreas transplant alone. Transplantation 2006, 81:67-68.
20. Scalea J.R., Scalea J.R., Butler C.C., Munivenkatappa R.B., Nogueira J.M., Campos L., et al. Pancreas transplant alone as an independent risk factor for the development of renal failure: a retrospective study. Transplantation 2008, 86:1789-1794.
21. Fioretto P., Najafian B., Sutherland D.E., Mauer M. Tacrolimus and cyclosporine nephrotoxicity in native kidneys of pancreas transplant recipients. Clin J Am Soc Nephrol 2011, 6:101-106.
22. Fioretto P., Sutherland D.E., Najafian B., Mauer M. Remodeling of renal interstitial and tubular lesions in pancreas transplant recipients. Kidney Int 2006, 69:907-912.
23. Senior P.A., Zeman M., Paty B.W., Ryan E.A., Shapiro A.M. Changes in renal function after clinical islet transplantation: four-year observational study. Am J Transplant 2007, 7:91-98.
24. Naziruddin B., Wease S., Stablein D., Barton F.B., Berney T., Rickels M.R., et al. HLA class I sensitization in islet transplant recipients-report from the Collaborative Islet Transplant Registry. Cell Transplant 2011 Nov 11, Epub ahead of print.
25. Cantarovich D., Vistoli F., Bignon J.D. Anti-human leukocyte antigen antibodies after islet transplantation: what do they really mean?. Transplantation 2008, 86:204-205.
26. Boggi U., Amorese G., Marchetti P. Surgical techniques for pancreas transplantation. Curr Opin Organ Transplant 2010, 15:102-111.
27. Boggi U., Vistoli F., Del Chiaro M., Signori S., Pietrabissa A., Costa A., et al. A simplified technique for the en bloc procurement of abdominal organs that is suitable for pancreas and small-bowel transplantation. Surgery 2004, 135:629-641.
28. Skupien J., Warram J.H., Smiles A.M., Niewczas M.A., Gohda T., Pezzolesi M.G., et al. The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease. Kidney Int 2012 May 23, [Epub ahead of print]. 10.1038/ki.2012.189.
29. Pancreas Allotransplantation for Diabetic Nephropathy and Mild Chronic Renal fAilure Stage Study (PANCREAS) Identifier: Principal Investigator: Diego Cantarovich, MD, PhD, Nantes University Hospital, Nantes, France. ctgov:NCT01067950.